MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Safety and Effect of Ecopipam During the First 8 Weeks of Treatment for Tourette Syndrome: A Post Hoc Analysis

    K. Tomczak, T. Katz, J. Flatt, G. Karkanias, S. Wanaski, T. Cunniff, D. Gilbert (Boston, USA)

    Objective: To assess the safety profile and effect of ecopipam, a selective dopamine D1 receptor antagonist, during the first 8 weeks of therapy for Tourette…
  • 2026 International Congress

    Patient-centered Parkinson’s services and integrated primary care in southern Ghana: patient and caregiver perceptions from a cross-sectional survey

    M. Agoriwo, M. Unger, C. Joseph, E. Franzén (Cape Town, South Africa)

    Objective: To evaluate patients’ and caregivers’ perceptions of patient-centered care for persons with Parkinson’s disease (PwPD) across three healthcare facilities in southern Ghana, and to…
  • 2026 International Congress

    Neurophysiologic Testing Aids Diagnosis of Stiff-person Spectrum Disorders

    J. Bower, F. Ali, L. Jackson, B. Klassen, A. Zekeridou, A. Hassan (ROCHESTER, USA)

    Objective: To develop standardized, quantifiable criteria when using neurophysiologic techniques to diagnose SPSD. Furthermore, we desired two levels of diagnostic certainty: Neurophysiology Possible for high…
  • 2026 International Congress

    Clinical and Psychophysiological Characteristics of Chronic Pain in Parkinson’s Disease: Pain Phenotypes, Central Sensitization, and Quality of Life

    B. Alieva, Y. Shpilyukova (Moscow, Russian Federation)

    Objective: To assess clinical characteristics and pain phenotypes in PD patients with different types of chronic pain, to assess the severity of central sensitization and…
  • 2026 International Congress

    Effects of Botulinum Toxin Therapy on Depression, Anxiety, Pain, and Quality of Life in Patients with Dystonia

    N. Başpınar, Z. Irmak, A. Ersöz, T. Akıncı, G. Yüksel (Istanbul, Turkey)

    Objective: To evaluate changes in depression,anxiety,pain, and quality of life alongside motor improvement in patients with dystonia treated with botulinum toxin(BoNT). Background: Dystonia is a…
  • 2026 International Congress

    Gut Microbiome Metagenomics in Parkinson’s Disease Stratified by the Asian-Prevalent LRRK2 Variants p.G2385R and p.R1628P

    TS. Toh, JW. Hor, CH. Lin, J. Tee, Z. Pan, AK. Ng, V. Balakrishnan, AN. Khairul Anuar, LC. Lit, CW. Chong, SY. Lim, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To compare gut microbiome profiles of manifesting LRRK2 p.G2385R or p.R1628P carriers (LRRK2-PD) and idiopathic Parkinson’s disease patients (iPD). Background: Leucine-rich repeat kinase 2…
  • 2026 International Congress

    Online Assessments Measure Motor and Cognitive Progression in People with and without Parkinson’s Disease

    E. Brown, X. Chen, P. Gonzalez Latapi, D. Weintraub, C. Marras, N. Pavese, L. Chahine, W. Poewe, R. Dobkin, K. Chou, E. Tolosa, A. Noyce, C. Stanley, T. Tropea, L. Racelo, M. Korell, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To evaluate longitudinal progression in online participant reported outcomes (PROs) among people with Parkinson’s disease (PD), prodromal PD, and healthy controls. Background: Collecting PROs…
  • 2026 International Congress

    High-Frequency rTMS for Cognitive Impairment in Parkinson’s Disease: A Randomized Sham-Controlled Trial in Veterans

    Y. Kim, S. Walker, K. Colletta, A. Umbarger, S. Kletzel (Maywood, USA)

    Objective: To evaluate the safety, feasibility, and potential cognitive effects of high-frequency rTMS targeting the left DLPFC in Veterans with PD-MCI. Background: Cognitive impairment is…
  • 2026 International Congress

    Differential expression of nucleotide excision repair genes in Parkinson’s disease

    PBR. Bermúdez Ramírez, SMS. Salas Pacheco, FCJ. Castellanos Juárez, JSP. Salas Pacheco, ASL. Salas Leal, ASC. Sandoval Carrillo (Durango, Mexico)

    Objective: To compare the relative expression of XPC, XPA, ERCC5, and ERCC4 between patients with Parkinson’s disease (PD) and controls. Background: DNA damage and impaired…
  • 2026 International Congress

    Characteristics And Progression Of Non-Motor Symptoms In Parkinsons Disease

    A. Shalash, M. Salama, M. Essam, Y. Mahran, E. Hamid, A. Helmy ()

    Objective: The aim of this study is to investigate the characteristics and the progression of different domains of NMS in PD, and to determine their…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley